ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 TROPHY-U-01 Cohort 3: Sacituzumab Govitecan + Pembrolizumab in mUC After Progression With Platinum-Based Regimens
By
ASCO Genitourinary Cancers Symposium
FEATURING
Petros Grivas
By
ASCO Genitourinary Cancers Symposium
FEATURING
Petros Grivas
108 views
March 8, 2022
Comments 0
Login to view comments.
Click here to Login
Videos